Cargando…

High-Dose Liraglutide and SGLT2 Inhibitor: A Promising Combination

Sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP-1) agonists are important drugs in our armamentarium of treatment for Type 2 diabetes mellitus (DM). In addition to their glucose-lowering effects, they have effects on weight, other metabolic diseases and perhaps mo...

Descripción completa

Detalles Bibliográficos
Autor principal: Chua, Marvin Wei Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788265/
https://www.ncbi.nlm.nih.gov/pubmed/35076486
http://dx.doi.org/10.3390/clinpract12010001